tm logo
SERATROL
Live/Registered
REGISTERED

on 08 Jun 2021

Last Applicant/ Owned by

41755 Elm Street, Suite 401

Murrieta

CA

92562

Serial Number

88614457 filed on 12th Sep 2019

Registration Number

6381133 registered on 08th Jun 2021

in the Principal Register

Correspondent Address

Benjamin Diederich

Benjamin Diederich

29826 HAUN RD., SUITE 311

MENIFEE, CA 92586

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SERATROL

Diagnostic preparations for clinical or medical laboratory use; biological tissue, namely, blood, blood powder, and human serum for scientific and medical research use; biological preparations, namely, human serum for laboratories, diagnostics and analytics for scientific or research use; and diagnostic preparations for scientific or research use

Classification Information


Class [001]
Chemical Products


Diagnostic preparations for clinical or medical laboratory use; biological tissue, namely, blood, blood powder, and human serum for scientific and medical research use; biological preparations, namely, human serum for laboratories, diagnostics and analytics for scientific or research use; and diagnostic preparations for scientific or research use


First Use Date in General

10th Mar 2021

First Use Date in Commerce

10th Mar 2021

Mark Details


Serial Number

No 88614457

Mark Type

No Service/Collective Mark

Attorney Docket Number

No BTINP-003T

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Jun 2021REGISTERED-PRINCIPAL REGISTER
04th May 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03rd May 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12th Apr 2021ASSIGNED TO EXAMINER
02th Apr 2021STATEMENT OF USE PROCESSING COMPLETE
01st Apr 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
16th Mar 2021USE AMENDMENT FILED
16th Mar 2021TEAS STATEMENT OF USE RECEIVED
18th Sep 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Sep 2020EXTENSION 1 GRANTED